Target intelligence / Profile preview

Streptococcus uberis surface and cell-wall antigens

Molecular classification
Bacterial surface protein, Antigen, Adhesin, Enzyme, Lipoprotein
01

Overview

Streptococcus uberis surface and cell-wall antigens are a diverse group of proteins and polysaccharides located on the exterior of the S. uberis bacterium, which is a leading cause of bovine mastitis worldwide. These antigens, such as the Streptococcus uberis adhesion molecule (SUAM) and the plasminogen activator (PauA), are critical for the pathogen's ability to adhere to, invade, and colonize the mammary gland (Almeida et al., 2011; Rosey et al., 1999). SUAM specifically facilitates binding to host lactoferrin, while PauA activates host plasminogen to promote tissue invasion and bacterial spread. These surface-exposed molecules serve as the primary targets for vaccine development, most notably the commercial UBAC vaccine, which utilizes cell-wall components to stimulate a protective immune response (Collado et al., 2018). By inducing the production of specific antibodies, these therapies aim to block bacterial attachment and enhance clearance by host immune cells through opsonophagocytosis. Despite their potential, the significant antigenic variation among different S. uberis strains remains a challenge for the development of a universally effective vaccine. Understanding the molecular structure of these antigens is essential for improving the efficacy of preventative treatments in the dairy industry.

Other names
Streptococcus uberis surface proteinsS. uberis cell wall proteinsBovine mastitis antigensStreptococcus uberis adhesion molecule (SUAM)Plasminogen activator uberis (PauA)GapC proteinOligopeptide-binding protein (OppA)
02

Mechanism of action

Vaccines targeting these antigens induce the production of specific antibodies (e.g., IgG1 and IgG2) that block bacterial adherence to mammary epithelial cells and neutralize virulence factors like PauA, thereby preventing the establishment of intramammary infection (Almeida et al., 2011; Collado et al., 2018).

03

Biological functions

Bacterial adhesionColonizationImmune evasionPathogenesisPlasminogen activationNutrient acquisition
04

Disease associations

Bovine mastitisInfection
05

Safety considerations

Injection site reactionsTransient hyperthermia in cattleVariable efficacy across diverse environmental strains
06

Interacting drugs

UBAC vaccine

1 more in the full profile.

07

Biomarkers

Somatic cell count (SCC)Serum IgG titers against SUAMMilk IgA levelsAnti-PauA antibody titers

Beyond the preview

Go deeper on Streptococcus uberis surface and cell-wall antigens.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Streptococcus uberis surface and cell-wall antigens.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call